Interviews and Features
A programme for change
Eoghan Ó Faoláin examines the medtech industry to see how it is coping and adapting to US regulatory change.
Book reviews
Paul O’Doherty takes a look at the latest life science titles on the bookshelves this summer
Enforcing on-time payment
Sinead Keogh, from the imda, looks at Medtech companies across Europe, particularly those under threat from late payments.
Life Sciences International Summit
The inaugural Life Sciences International Summit takes place October 6th at Croke Park, Dublin and aims to provide an overview of the many challenges facing the sector and, crucially, Ireland’s place within it.
Out of the West
Louise Hodgson meets John O’Dea, CEO and founder of Crospon, to discuss the recent success and plans of the EndoFLIP technology, which has just been launched in the US, and his views on the changing medical-devices sector.
Re-booting DDT
Henry Miller looks at malaria treatments and argues that in the absence of a vaccine, elimination of the mosquitoes that spread the disease is the key to preventing epidemics.
The future for biotech
Niamh Mac Sweeney reviews the BIO International convention and finds a worldwide community of leaders determined to accelerate the growth of the biosciences.
A workforce to be reckoned with
Life sciences skillnet will improve manufacturers’ competitiveness and increase productivity, writes Pauline O’Flanagan.
Committed to competition
With blockbuster drugs coming off patent,Niamh Mac Sweeney talks to Matt Moran, of PharmaChemical Ireland about the targets, the challenges and the opportunities for the industry.
Life changing collaboration
An Irish research project will develop a more accurate test for thyroid disorders and offers a unique opportunity to address an unmet healthcare need.
Preparing for a life outside the lab
Although the life science industry is facing into challenging times, there is light at the end of the tunnel, writes Richard Hayes.
Sewing seeds for the future
Killian O’Driscoll examines how Ireland can maintain and develop its hard-won reputation in the pharmaceutical sector.
Taxing matters
Tax issues will play a bigger role in global pharmaceutical company valuations and business strategies.
The challenge for industry
Dr Claire Power examines the factors that need to be considered when calculating a patent-expiry date.
